Key facts
- It has raised $10.1M; the latest was Later Stage VC ($2.2M) in Jun 2024.
- Notable investors include Nova Capital (Italy), APEX Ventures, B&C Industry Holding, Crista Galli Ventures, European Innovation Council (Belgium) — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Contextflow
- ·The full record, as it builds
Funding rounds
No funding rounds for Contextflow are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Contextflow
Developer of an AI-based decision support software designed for radiology image analysis and detection, applied for respiratory diseases. The company offers diagnostic and radiology workflows, with a focus on enhancing patient care, CE-marked computer vision detection system that quantifies and reveals lung nodules and distinctive other image patterns in real-time, integration of overlay front-end into any PACS system, enabling practitioners to improve the efficiency and quality of care for all participants in the radiology workflow chain.
- Sector
- Healthcare
- HQ
- Vienna, Austria
- Founded
- 2016
- Employees
- 35
- Website
- contextflow.com/
- Ownership
- Privately Held (backing)
Contextflow doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Contextflow shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Contextflow in its N-PORT filings yet. We sweep new filings monthly.